Delivery Order SPE2DB22D3501-SPE2DB25FUX81

Award Date 3/14/25
Potential Completion Date 3/17/25
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,173.19, is for the procurement of Omnipod 5 DEXCOM7 G6 Pods (Gen 5) 5S for medical use. It is a firm fixed-price delivery order contract with a period of performance through February 7, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a $3,689.86 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OMNIPOD 5 DEXCOM G7 glucose monitoring pods (Generation 5) to support federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,867.44, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. It is a firm fixed-price delivery order contract with a completion date of February 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,059.15, is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of February 28, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This federal contract award, valued at $15,540.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of February 6, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,387.04 Firm Fixed Price Delivery Order is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. The contract has an ultimate completion date of February 28, 2025 and was awarded on February 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of OMNIPOD 5 DEXCOM7 G6 PODS (Gen 5), medical devices used for diabetes management. The contract has a ceiling value of $4,287.93 and runs through March 7, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was...
This federal contract award, valued at $1,790.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of February 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,193.52, is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices. It is a firm-fixed-price contract with a completion date of February 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $1,396.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S medical devices, with a completion date of March 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FUX81
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $1,790.28, is a Firm Fixed Price Delivery Order for the procurement of OMNIPOD 5 DEXCOM G7 Glucose Monitoring System Pods (Generation 5). The contract has a period of performance through March 17, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award was not designated with a set-aside requirement, indicating open competition.

Generated 6/13/25, 10:06 AM